MyoKardia
MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases.
Business Model:
Revenue: $47.2B
Employees: 51-200
Rankings
Industries / Tags:
Detailed MyoKardia Information
MyoKardia was acquired by
Bristol Myers Squibb.
The acquisition happend on 2020-10-05.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1000 Sierra Point Parkway
City: Brisbane
State: CA
Zip: 94005
Country: US
Financial Info
Stage:
series b
Raised Last:
$46M
Raised Total:$98M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases.
Contact Phone:
+16507410900
Contact Email:
MyoKardia went public on 10/29/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/29/2015
Ticker Symbol:
MYOK
IPO Price:
$10/share
Amount Raised:
$54M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
